![](/static/images/TCI-site-logo.png)
tci Medicare Compliance & Reimbursement - 2006 Issue 19
PRESCRIPTION DRUGS: OIG To CMS--51 Drugs May Be Overpriced
CMS disputes OIGs calculations, however.A few dozen Part B drugs could be facing steep drops in their already-low reimbursements soon. The law gives the Centers for Medicare & Medicaid Services the authority to slash drug payments if the average sales price (ASP) is at least 5 percent higher than the average price the manufacturer actually charges. Medicare pays for Part B drugs based on ASP plus 6 percent. And the HHS Office of Inspector General's latest report says that 51 drugs had ASPs that were at least 5 percent higher than manufacturer prices, if you use CMS's...
To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.
Thank you for choosing Find-A-Code, please Sign In to remove ads.